Advances in upper airway diseases and allergen immunotherapy

Journal of Allergy and Clinical Immunology

Volumn 113, Issue 4, 2004, Pages 635-642

  Nelson, Harold S ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Immunotherapy; One airway; Rhinitis; Sinusitis; Upper airway

Indexed keywords

ACRIVASTINE; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; ASTEMIZOLE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ; BUDESONIDE; CETIRIZINE; CHLORPHENIRAMINE; CORTICOSTEROID; DESLORATADINE; DIPHENHYDRAMINE; FEXOFENADINE; GLUCOCORTICOID; HYDROXYZINE; LORATADINE; METHACHOLINE; OMALIZUMAB; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TERFENADINE; TRIAMCINOLONE;

ASTHMA; BASEMENT MEMBRANE; BIRCH; BIRTH WEIGHT; CELL DAMAGE; CLINICAL TRIAL; CONGENITAL MALFORMATION; CYTOKINE RELEASE; DANDER; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; EOSINOPHILIC ENTERITIS; EPITHELIUM CELL; ESOPHAGITIS; FIRST TRIMESTER PREGNANCY; HISTOLOGY; HUMAN; IMMUNOTHERAPY; LOWER RESPIRATORY TRACT; NONHUMAN; PERENNIAL RHINITIS; PHENOTYPE; POLLEN; POLLEN ALLERGY; PREGNANCY COMPLICATION; PRICK TEST; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SEASONAL VARIATION; SEDATION; SIDE EFFECT; SINUSITIS; SKIN TEST; SPONTANEOUS ABORTION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; THICKNESS; UPPER RESPIRATORY TRACT INFECTION;

EID: 1942435988     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.01.741     Document Type: Review

References (38)

1. Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol 2003;111:1171-83.
2. McCusker C, Chicoine M, Hamid Q, Mazer B. Site-specific sensitization in a murine model of allergic rhinitis: role of the upper airway in lower airways disease. J Allergy Clin Immunol 2002;110:891-8.
3. Sandrini A, Ferreira IM, Jardin JR, Zamel N, Chapman KR. Effect of nasal triamcinolone acetonide on lower airway inflammatory markers in patients with allergic rhinitis. J Allergy Clin Immunol 2003;111:313-20.
4. Magnusson J, Lin XP, Dahlman-Hoglund A, Hanson LA, Telemo E, Magnusson O, et al. Seasonal intestinal inflammation in patients with birch pollen allergy. J Allergy Clin Immunol 2003;112:45-51.
5. Fogg MI, Ruchelli E, Spergel JM. Pollen and eosinophilic esophagitis. J Allergy Clin Immunol 2003;112:796-7.
6. Iwasaki M, Saito K, Takemura M, Sekikawa K, Fujii H, Yamada Y, et al. TNF-α contributes to the development of allergic rhinitis in mice. J Allergy Clin Immunol 2003;111:134-40.
7. Cates EC, Gajewska BU, Goncharova S, Alverez D, Fattouh R, Coyle AJ, et al. Effect of GM-CSF on immune, inflammatory, and clinical responses to ragweed in a novel mouse model of mucosal sensitization. J Allergy Clin Immunol 2003;111:1076-86.
8. Eddleston J, Christiansen SC, Jenkins GR, Koziol JA, Zuraw BL, Bradykinin increases the in vivo expression of the CXC chemokine receptors CXCR and CXCR2 in patients with allergic rhinitis. J Allergy Clin Immunol 2003;111:106-12.
9. Steinke JW, Bradley D, Arango P, Crouse CD, Frierson H, Kountakis SE, et al. Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma. J Allergy Clin Immunol 2003;111:343-9.
10. Ponikau JU, Sherris DA, Kephart GM, Kern EB, Gaffey TA, Tarara JE, et al. Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: Is the histopathology similar to asthma? J Allergy Clin Immunol 2003;112:877-82.
11. Ponikau JU, Sherris DA, Kita H, Kern EB. Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol 2002;110:862-6.
12. Moretti ME, Caprara D, Coutinho CJ, Bar-Oz B, Berkovitch M, Addis A, et al. Fetal safety of loratadine use in the first trimester of pregnancy: a multicenter study. J Allergy Clin Immunol 2003;111:479-83.
13. Diav-Citrin O, Shechtman S, Aharonovich A, Moerman L, Arnon J, Wajnberg R, et al. Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study. J Allergy Clin Immunol 2003;111:1239-43.
14. Simons EFR, Silas P, Portnoy JM, Catuogno J, Chapman D, Olufade AO. Safety of cetirizine in infants 6 to 11 months of age: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol 2003; 111:1244-8.
15. Wahn U, Meltzer EO, Finn AF, Kowalski ML, Decosta P, Hedlin G, et al. Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis. J Allergy Clin Immunol 2003;111:763-9.
16. Simons FER, Prenner BM, Finn A Jr. Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol 2003;111:617-22.
17. Bender BG, Berning S, Dudden R, Milgrorn H, Tran ZV. Sedation and performance impairment of diphenhydramine and second-generation antihistamines: a meta-analysis. J Allergy Clin Immunol 2003;111: 770-6.
18. Law AW, Reed SD, Sundy JS, Schulman KA. Direct costs of allergic rhinitis in the United States: estimates from the 1996 Medical Expenditure Panel Survey. J Allergy Clin Immunol 2003;111: 296-300.
19. Mastruzzo C, Greco LR, Nakano K, Nakano A, Palermo F, Pistoria MP, et al. Impact of intranasal budesonide on immune inflammatory response s and epithelial remodeling in chronic upper airway inflammation. J Allergy Clin Immunol 2003;112:37-44.
20. Kopp MV, Brauburger J, Riedinger F, Beischer D, Ihorst G, Kamin W, et al. The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis. J Allergy Clin Immunol 2002; 110:728-35.
21. Feuchtinger T, Bartz H, von Berg A, Riedinger F, Brauburger J, Stenglein S, et al. Treatment with omalizumab normalizes the number of myeloid dendritic cells during the grass pollen season. J Allergy Clin Immunol 2003;111:428-9.
22. Bryce PJ, Geha R, Oettgen HC. Desloratadine inhibits allergen-induced airway inflammation and bronchial hyperresponsiveness and alters T-cell responses in murine models of asthma. J Allergy Clin Immunol 2003; 112:149-58.
23. Fiset P-O, Soussi-Gounni A, Christodoulopoulos P, Tulic M, Sobol SE, Frenkiel S, et al. Modulation of allergic response in nasal mucosa by antisense oligodeoxynucleotides for IL-4. J Allergy Clin Immunol 2003; 111:580-6.
24. Juniper EF, Rohrbaugh T, Meltzer EO. A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2003;111:484-90.
25. Roberts G, Hurley C, Lack G. Development of a quality-of-life assessment for the allergic child or teenager with multisystem allergic disease. J Allergy Clin Immunol 2003;111:491-7.
26. Weber RW. Patterns of pollen cross-allergenicity. J Allergy Clin Immunol 2003;112:229-39.
27. Gijzen M, Gonziez R, Barber D, Polo F. Levels of airborne Gly m 1 in regions of soybean cultivation. J Allergy Clin Immunol 2003;112:803-5.
28. Maccario J, Oryszczyn M-P, Charpin D, Kauffmann F. Methodologic aspects of the quantification of skin prick test responses: the EGEA study. J Allergy Clin Immunol 2003;111:750-6.
29. Bodtger U, Poulsen LK, Mailing H-J. Asymptomaic skin sensitization to birch predicts later development of birch pollen allergy in adults: a 3-year follow-up study. J Allergy Clin Immunol 2003;111:149-54.
30. Liccardi G, Salzillo A, Spadaro G, Senna G, Canonica WG, D'Amato G, et al. Anaphylaxis caused by skin prick testing with aeroallergens: case report and evaluation of the risk in Italian allergy services. J Allergy Clin Immunol 2003;111:1410-2.
31. Ewbank PA, Murray J, Sanders K, Curran-Everett D, Dreskin S, Nelson HS. A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract. J Allergy Clin Immunol 2003;111: 155-61.
32. Trivedi B, Valerio C, Slater JE. Endotoxin content of standardized allergen vaccines. J Allergy Clin Immunol 2003;111:777-83.
33. Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003;111:437-48.
34. Liu Y-H, Kao M-C, Lai Y-L, Tsai J-J. Efficacy of local nasal immunotherapy for Dp2-induced airway inflammation in mice: using Dp2 peptide and fungal immunomodulatory peptide. J Allergy Clin Immunol 2003;112:301-10.
35. Victor JR, Fusaro AE, de Silva Duarte AJ, Sato MN. Preconception maternal immunization to dust mite inhibits the type 1 hypersensitivity response of offspring. J Allergy Clin Immunol 2003;111:269-77.
36. Francis JN, Til SJ, Durham SR. Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003;111: 1255-61.
37. Zemann B, Schwaerzler C, Griot-Wenk M, Nefzger M, Mayer P, Schneider H, et al. Oral administration of specific antigens to allergy-prone infant dogs induces IL-10 and TGF-β expression and prevents allergy in adult life. J Allergy Clin Immunol 2003;111:1069-75.
38. Wachholz PA, Soni NK, Till SJ, Durham SR. Inhibition of allergen-IgE binding to B-cells by IgG antibodies following grass pollen immunotherapy. J Allergy Clin Immunol 2003;112:915-22.